Portfolio Lab

Doximity, Inc.

  • Stock
  • Ticker DOCS
  • NYSE

Technology · Software and IT services · USA

$28.73 −2.97%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Doximity, Inc. since 06/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

DOCSGlobal equities (VT)

$10,000 grew to $4,135. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −82.3% in 05/2026, measured from the peak in 09/2021. The old peak has not been reached again yet.

1-year return
−38.1%
5-year return p.a.
−14.0%
Return p.a. since 06/2021
−10.7%
Volatility p.a.
57.6%
Largest decline
−82.3%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue169138146169185145157175
Gross profit154124130152166126133149
Operating income8049556472253444
EBITDA8152576674293848
Net income7562536262192435
Earnings per share0.370.310.270.310.310.100.130.18
Balance sheet
Total assets1,1721,2641,2041,2571,1571,1241,0841,092
Liabilities141182179162178173168163
Equity1,0311,0831,0261,096979951916928
Cash16521013716965219274219
Cash flow
Operating cash flow65986294611104293
Capital expenditure0.00.00.00.0––-0.10.0
Free cash flow65986294611104293

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +90.4%, weakest 2022 at −33.1%. 1 of 4 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.18
6 Aug 2026$0.13
19 May 2026$0.10
5 Feb 2026$0.31
6 Nov 2025$0.31
7 Aug 2025$0.27
20 May 2025$0.31
6 Feb 2025$0.37
7 Nov 2024$0.22
8 Aug 2024$0.21
23 May 2024$0.20
8 Feb 2024$0.24

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€4.6bn
Market cap in trading currency
$5.12bn
Enterprise value
$4.90bn
P/E
39.9
P/S
7.74
P/B
5.52
EV/Sales
7.41
EV/EBITDA
25.9
Earnings yield
2.5%
FCF yield
6.0%

Results (last four quarters)

Revenue
$662m
Gross profit
$574m
EBITDA
$189m
Net income
$140m
Earnings per share
$0.72
Revenue per share
$3.71
Revenue growth
+3.6%
Earnings growth
−44.0%

Profitability

Gross margin
86.8%
Operating margin
26.3%
Net margin
21.1%
Return on equity
13.8%
Return on assets
12.8%

Balance sheet and cash flow

Cash
$219m
Cash per share
$1.23
Financial debt
–
Debt/equity %
–
Current ratio
6.37
Book value per share
$5.21
Operating cash flow
$306m
Free cash flow
$306m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
178m
Volume
2.34m
Avg. volume 3 months
2.81m
Relative volume
0.9

Price and technicals

Price
$28.73
1 day
−3.0%
52-week high
$51.53
52-week low
$18.01
Distance to 52-week high
−44.2%
Distance to 52-week low
+59.5%
Distance to 50-day line
−5.1%
Distance to 200-day line
+14.6%
RSI (14)
35
Volatility 1M
41.1%

Performance

1 week
−13.8%
1 month
−14.7%
3 months
+13.6%
6 months
+44.1%
YTD
−35.1%
1 year
−40.1%

Dates

Fiscal year end
31 Mar 2026
Most recent quarter
30 Sep 2026

Frequently asked questions

How has DOCS performed since 06/2021?

$10,000 grew to $5,421 by 20 Nov 2026, which is −10.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is DOCS?

Volatility was 57.6% per year, measured on monthly returns. The largest decline from a peak was −82.3%, with the low in 05/2026.

How does DOCS compare with a broad equity ETF?

Over the same period Global equities (VT) returned +8.1% per year at 15.1% volatility, DOCS returned −10.7% at 57.6%. The correlation of monthly returns was 0.36; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Doximity, Inc. (DOCS): Return and risk | Portfolio Lab